Phase 2 Oncology Study

Advertisement

cGxPJobs Banner

Processa Triggers Interim Analysis in Phase 2 Breast Trial

VERO BEACH, Fla. | January 5, 2026 — Processa Pharmaceuticals, Inc. has completed enrollment and dosing of the 20th...

By cGxPwire Editor
January 6, 2026

Read More

Advertisement

cGxPJobs

Directory